GGrantIndex
Sort

50,496 grants matching lung cancer

Bringing 4π radiation therapy to the clinic

$1,132,278
Jay Yonemoto · Celestial Oncology Inc. · R44 · FY2022 · CA

Point-of-Care Microfluidics in Lung Cancer

$1,132,105
Mehmet Toner · Massachusetts General Hospital · R01 · FY2007 · EB

Clinical production of viral vectors for cancer gene therapy

$1,131,975
Rachel Beyer · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA

Multi-Center Study of Pancreatic Cancer Etiology

$1,131,891
John D Potter · Kaiser Foundation Health Plan Of Washington · R01 · FY2007 · CA

Bio-Therapies for the Treatment of Cancer and Infectious Disease

$1,131,591
David Fitzgerald · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Emergency Myelopoiesis in the Control of Blood Production

$1,131,261
Emmanuelle Passegue · Columbia University Health Sciences · R35 · FY2024 · HL

National Resource for Translational and Developmental Proteomics

$1,131,251
Neil L Kelleher · Northwestern University · P41 · FY2017 · GM

Identification of Single Nucleotide Polymorphisms in Cancer-Related Genes

$1,131,249
Michael Dean · Basic Sciences · Z01 · FY2007 · CA

ASPiRE: Advancing Science & Practice in the Retail Environment

$1,130,943
Kurt M. Ribisl · Univ Of North Carolina Chapel Hill · P01 · FY2023 · CA

SARS-CoV-2-reactive tissue-resident memory T cells in healthy and cancer subjects

$1,130,292
Pandurangan Vijayanand · La Jolla Institute For Immunology · U01 · FY2023 · CA

Stromal Regulation of Bone Metastasis

$1,129,443
Raghu Kalluri · University Of Tx Md Anderson Can Ctr · U54 · FY2015 · CA

Clinical Development of First-in-Class Therapy for Metastatic Breast Cancer

$1,129,316
Zdravka O. Medarova · Transcode Therapeutics, Inc. · R44 · FY2022 · CA

Decoding And Targeting The LKB1-AMPK Signaling Pathway In Cancer

$1,129,078
Reuben J Shaw · Salk Institute For Biological Studies · R35 · FY2019 · CA

Targeted Discovery of Marine-derived Anticancer Leads

$1,128,979
Phil Crews · University Of California Santa Cruz · U19 · FY2006 · CA

Comparative Oncology Program Laboratory

$1,128,805
Amy Leblanc · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma

$1,128,637
Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Telehealth Research and Innovation for Veterans with Cancer (THRIVE)

$1,128,603
Scott E Sherman · New York University School Of Medicine · P50 · FY2022 · CA

Thyroid Hormone Receptors in Health and Disease

$1,128,499
Sheue-Yann Cheng · Basic Sciences · Z01 · FY2007 · CA

Technology to Unmask Accessible Tumor Vascular Targets

$1,128,364
Sidney Kimmel Cancer Center · R33 · FY2002 · CA

Preclinical development of Ala+TIMP-2 as an cancer therapeutic

$1,128,123
William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Non-canonical functions of neutrophils

$1,127,962
Andres Hidalgo · Yale University · R01 · FY2025 · AI

Center of Excellence for Cancer Research, Training and Community Service

$1,127,952
Karam F.a. Soliman · Florida Agricultural And Mechanical Univ · P20 · FY2014 · MD

Treating non-small cell lung tumors with a novel inhaled dry powder chemotherapeutic formulation

$1,127,538
Bryce Beverlin II · Quench Medical, Inc. · R44 · FY2023 · CA

DCTD Human Toxicology and Pharmacology

$1,127,454
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2016 · CA

Molecular Pathology of Pulmonary Carcinogenesis

$1,126,875
Ilona Linnoila · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA